Methylphenidate Safety in Anxiety Disorder

Introduction to Methylphenidate Safety

• In patients with anxiety disorders, methylphenidate can cause behavioral activation or agitation, particularly early in treatment or with dose increases, but this is a functional side effect, not neuronal damage, as reported by the American Academy of Child and Adolescent Psychiatry 1

Monitoring and Administration

• Monitor for anxiety symptoms particularly in the first month of treatment or after dose increases, as this is when behavioral activation is most likely, according to the American Academy of Child and Adolescent Psychiatry 1
• If restarting methylphenidate or trying a different formulation, use slow up-titration starting at a low dose to minimize behavioral activation, as suggested by a medical insights guideline 2
• Consider switching to extended-release formulations which may have a lower risk of peak-related anxiety compared to immediate-release preparations, based on a practical summary of clinical guidelines 3